2017 annual financial data
Rigel Pharmaceuticals 2017 Operating margin
Direct answer
Operating margin was -1,775.56%.
Operating income was -79,616,000 USD and net income was -77,992,000 USD.
Operating cash flow was -77,557,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,484,000 USD
- Operating income
- -79,616,000 USD
- Net income
- -77,992,000 USD
- Operating cash flow
- -77,557,000 USD